James M. Thorburn, Chief Financial Officer at Twist Bioscience Corp (TWST), sold 13,197 shares at $35.88 ($479K) on 2022-05-20, disclosed to the SEC on 2022-05-24.
Open-market sale of $479k TWST by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.04 | 1,850 | $65K | 13.5% |
| 2 | $35.88 | 2,526 | $91K | 18.9% |
| 3 | $35.88 | 2,526 | $91K | 18.9% |
| 4 | $36.92 | 2,101 | $78K | 16.2% |
| 5 | $36.92 | 2,101 | $78K | 16.2% |
| 6 | $36.99 | 1,027 |
| $38K |
| 7.9% |
| 7 | $37.72 | 143 | $5K | 1.1% |
| 8 | $36.55 | 406 | $15K | 3.1% |
| 9 | $37.18 | 517 | $19K | 4.0% |
| Total | $36.27 avg | 13,197 | $479K | 100% |
| Filing → |
| TWST | SELL | 2022-03-07 | $359K | — | Filing → |
| TWST | SELL | 2022-02-23 | $432K | — | Filing → |
| TWST | SELL | 2021-12-10 | $1.1M | — | Filing → |